Jaka jest cena za GeneReach Biotechnology Corp. (4171)

Cena za GeneReach Biotechnology Corp. (4171) wynosi $0.54217343

Jaka jest kapitalizacja rynkowa dla GeneReach Biotechnology Corp. (4171)

Kapitalizacja rynkowa dla GeneReach Biotechnology Corp. (4171) wynosi $31.07M

GeneReach Biotechnology Corp. (4171) EPS

GeneReach Biotechnology Corp., a company based in Taichung, Taiwan, specializes in the development, production, and commercialization of advanced nucleic acid detection technologies. The company's extensive product line features essential laboratory instrumentation, including automated nucleic acid extraction systems, prep homogenization systems, and mini centrifuges. GeneReach also provides a wide range of reagents and consumables, such as human In Vitro Diagnostic (IVD) assays, specific iiPCR reagents, taco nucleic acid extraction reagents, IQ real quantitative systems, IQ2000 detection and prevention systems, and various research-grade reagents and supplies. Beyond its product offerings, GeneReach delivers comprehensive services. These encompass polymerase chain reaction (PCR) training programs, expert molecular diagnostic technical solutions, laboratory installation assistance, OEM/ODM contract manufacturing capabilities, and collaborative research services. Its innovative solutions cater to a diverse clientele, with applications spanning aquaculture, agriculture, food safety, human health, and the welfare of companion animals and livestock. GeneReach Biotechnology Corp. was established in 2004.

Rok	EPS	Zmień
Za mało danych dla podanych dat.

Rok

EPS

Zmień

Za mało danych dla podanych dat.

Firma	EPS	Różnica w EPS	Kraj
Vertex Pharmaceuticals Incorporated VRTX.US	$17.32	-	US
Moderna, Inc. MRNA.US	$-7.98	-	US
Argenx SE ARGX.US	$27.74	-	NL
CSL Limited CSL.AX	$2.98	-	AU
Lonza Group AG LONN.SW	-	-	CH

Firma

EPS

Różnica w EPS

Kraj